drugset / Trial / NCT01195779
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this observer-blind study is to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals' influenza vaccine GSK2584786A in healthy children 6 to 35 months of age.
Timeline
- Start
- 2010-09-30
- Primary completion
- 2011-03-22
- Completion
- 2011-03-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK2321138A | Vaccine | — | Intramuscular |
| Subject | GSK2584786A | Vaccine | — | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | — | Intramuscular |